NCT00568113View on ClinicalTrials.gov

N-Acetyl Cysteine for Prevention of Preterm Birth

PHASE4CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 31, 2007

Study Completion Date

December 31, 2007

Conditions

Preterm Labour

Interventions

DRUG

acetylcysteine in arm 1

"Arm 2, control group: given hydroxyl progesterone caproate (150mgm) every 3 days starting from the 28th week of pregnancy till completed 36 weeks of gestation.~Arm 1 patients were given hydroxyl progesterone caproate (150mgm) weekly injections plus NAC 0.6 gm (Sedico, Egypt) orally daily starting from the 28th week of pregnancy till delivery or completed 36th week of pregnancy."

Trial Locations (1)

71116

Ahmed Youssif Shahin, Asyut

All Listed Sponsors

lead

Assiut University

OTHER

NCT00568113 - N-Acetyl Cysteine for Prevention of Preterm Birth | Biotech Hunter | Biotech Hunter